SEC Form 4 · accession 0001104659-16-141236
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President and General Counsel · Director
Period of report
Aug 22, 2016
Accepted (ET)
Aug 24, 2016 · 6:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 22, 2016 | M | 10,000 | $10.46 | A | 212,961 | D | |
| Common Stock | Aug 22, 2016 | S | 10,000 | $19.95 | D | 202,961 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $10.46 | Aug 22, 2016 | M | 10,000 | D | — | Jul 13, 2022 | Common Stock | 10,000 | 46,996 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2015.
- F2Shares subject to the option are fully vested and immediately exercisable.